These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 14712088)

  • 1. B-raf and insulin synergistically prevent apoptosis and induce cell cycle progression in hematopoietic cells.
    Shelton JG; Chang F; Lee JT; Franklin RA; Steelman LS; McCubrey JA
    Cell Cycle; 2004 Feb; 3(2):189-96. PubMed ID: 14712088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential abilities of the Raf family of protein kinases to abrogate cytokine dependency and prevent apoptosis in murine hematopoietic cells by a MEK1-dependent mechanism.
    Hoyle PE; Moye PW; Steelman LS; Blalock WL; Franklin RA; Pearce M; Cherwinski H; Bosch E; McMahon M; McCubrey JA
    Leukemia; 2000 Apr; 14(4):642-56. PubMed ID: 10764150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of deregulated Raf activation on integrin, cytokine-receptor expression and the induction of apoptosis in hematopoietic cells.
    Weinstein-Oppenheimer C; Steelman LS; Algate PA; Blalock WL; Burrows C; Hoyle PE; Lee JT; Moye PW; Shelton JG; Franklin R; McCubrey JA
    Leukemia; 2000 Nov; 14(11):1921-38. PubMed ID: 11069028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ability of the activated PI3K/Akt oncoproteins to synergize with MEK1 and induce cell cycle progression and abrogate the cytokine-dependence of hematopoietic cells.
    Shelton JG; Blalock WL; White ER; Steelman LS; McCubrey JA
    Cell Cycle; 2004 Apr; 3(4):503-12. PubMed ID: 15004527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the RAF/MEK/ERK and PI3K/AKT signal transduction pathways on the abrogation of cytokine-dependence and prevention of apoptosis in hematopoietic cells.
    Shelton JG; Steelman LS; Lee JT; Knapp SL; Blalock WL; Moye PW; Franklin RA; Pohnert SC; Mirza AM; McMahon M; McCubrey JA
    Oncogene; 2003 Apr; 22(16):2478-92. PubMed ID: 12717425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential abilities of activated Raf oncoproteins to abrogate cytokine dependency, prevent apoptosis and induce autocrine growth factor synthesis in human hematopoietic cells.
    McCubrey JA; Steelman LS; Hoyle PE; Blalock WL; Weinstein-Oppenheimer C; Franklin RA; Cherwinski H; Bosch E; McMahon M
    Leukemia; 1998 Dec; 12(12):1903-29. PubMed ID: 9844921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P21(Cip1) induced by Raf is associated with increased Cdk4 activity in hematopoietic cells.
    Chang F; McCubrey JA
    Oncogene; 2001 Jul; 20(32):4354-64. PubMed ID: 11466616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Raf-induced cell cycle progression in human TF-1 hematopoietic cells.
    Chang F; Steelman LS; McCubrey JA
    Cell Cycle; 2002; 1(3):220-6. PubMed ID: 12429936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of kinase cascade inhibitors on neoplastic and cytokine-mediated cell proliferation.
    Shelton JG; Moye PW; Steelman LS; Blalock WL; Lee JT; Franklin RA; McMahon M; McCubrey JA
    Leukemia; 2003 Sep; 17(9):1765-82. PubMed ID: 12970777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergy between PI3K/Akt and Raf/MEK/ERK pathways in IGF-1R mediated cell cycle progression and prevention of apoptosis in hematopoietic cells.
    Shelton JG; Steelman LS; White ER; McCubrey JA
    Cell Cycle; 2004 Mar; 3(3):372-9. PubMed ID: 14726697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a conditional in vivo model to evaluate the efficacy of small molecule inhibitors for the treatment of Raf-transformed hematopoietic cells.
    Konopleva M; Shi Y; Steelman LS; Shelton JG; Munsell M; Marini F; McQueen T; Contractor R; McCubrey JA; Andreeff M
    Cancer Res; 2005 Nov; 65(21):9962-70. PubMed ID: 16267021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergy between Raf and BCL2 in abrogating the cytokine dependency of hematopoietic cells.
    Moye PW; Blalock WL; Hoyle PE; Chang F; Franklin RA; Weinstein-Oppenheimer C; Pearce M; Steelman L; McMahon M; McCubrey JA
    Leukemia; 2000 Jun; 14(6):1060-79. PubMed ID: 10865973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined effects of aberrant MEK1 activity and BCL2 overexpression on relieving the cytokine dependency of human and murine hematopoietic cells.
    Blalock WL; Moye PW; Chang F; Pearce M; Steelman LS; McMahon M; McCubrey JA
    Leukemia; 2000 Jun; 14(6):1080-96. PubMed ID: 10865974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Requirement for the PI3K/Akt pathway in MEK1-mediated growth and prevention of apoptosis: identification of an Achilles heel in leukemia.
    Blalock WL; Navolanic PM; Steelman LS; Shelton JG; Moye PW; Lee JT; Franklin RA; Mirza A; McMahon M; White MK; McCubrey JA
    Leukemia; 2003 Jun; 17(6):1058-67. PubMed ID: 12764369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of Raf-1 and mitogen-activated protein kinase in murine macrophages partially mimics lipopolysaccharide-induced signaling events.
    Hambleton J; McMahon M; DeFranco AL
    J Exp Med; 1995 Jul; 182(1):147-54. PubMed ID: 7790814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a conditionally active v-ErbB and an EGF-R inhibitor on transformation of NIH-3T3 cells and abrogation of cytokine dependency of hematopoietic cells.
    McCubrey JA; Shelton JG; Steelman LS; Franklin RA; Sreevalsan T; McMahon M
    Oncogene; 2004 Oct; 23(47):7810-20. PubMed ID: 15361836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of beta-estradiol on Raf activity, cell cycle progression and growth factor synthesis in the MCF-7 breast cancer cell line.
    Weinstein-Oppenheimer CR; Burrows C; Steelman LS; McCubrey JA
    Cancer Biol Ther; 2002; 1(3):256-62. PubMed ID: 12432273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of cell cycle progression and apoptosis by the Ras/Raf/MEK/ERK pathway (Review).
    Chang F; Steelman LS; Shelton JG; Lee JT; Navolanic PM; Blalock WL; Franklin R; McCubrey JA
    Int J Oncol; 2003 Mar; 22(3):469-80. PubMed ID: 12579299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions between the PI3K and Raf signaling pathways can result in the transformation of hematopoietic cells.
    McCubrey JA; Lee JT; Steelman LS; Blalock WL; Moye PW; Chang F; Pearce M; Shelton JG; White MK; Franklin RA; Pohnert SC
    Cancer Detect Prev; 2001; 25(4):375-93. PubMed ID: 11531015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
    McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
    Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.